Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)-
Epileptic Spasm
Children's Hospital of Orange CountySmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Epileptic Spasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE University of California, Los Angeles | Phase 4 | BBB |
Corticotropin All India Institute of Medical Sciences | Phase 4 | BBB |
Vitamin B6 Lady Hardinge Medical College | Phase 3 | BB |
Vigabatrin Amzell | Phase 4 | BB |
gwp42003-p Jazz Pharmaceuticals | Phase 3 | BB |
View all 18 →
Same molecule, other indications
Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →